Therapeutic impact of red blood cell transfusion on anemic outpatients: the RETRO study.

导出 OA

翻译打印收藏纠错

作者： Elizabeth,St Lezin ^[1] ; Matthew S,Karafin ^[2] ; Roberta,Bruhn ^[3] ; Dhuly,Chowdhury ^[1] ; Lirong,Qu ^[4] ; Walter,Bialkowski ^[5] ; Scott,Merenda ^[6] ; Pamela,D'Andrea ^[3] ; Anne-Lyne,McCalla ^[7] ; Lisa,Anderson ^[8] ; Sheila M,Keating ^[9] ; Mars,Stone ^[3] ; Edward L,Snyder ^[4] ; Donald,Brambilla ^[4] ; Edward L,Murphy ^[7] ; Philip J,Norris ^[5] ; Joan F,Hilton ^[1] ; Bryan R,Spencer ^[4] ; Steven,Kleinman ^[1] ; Jeffrey L,Carson ^[4] ; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS)-III Program ^[1]

作者单位： Department of Laboratory Medicine, University of California San Francisco, San Francisco, California. ^[1] Department of Laboratory Medicine, San Francisco Veterans Affairs Health Care System, San Francisco, California. ^[2] Medical Sciences Institute (MSI), BloodCenter of Wisconsin, Milwaukee, Wisconsin. ^[3] Vitalant Research Institute, San Francisco, California. ^[4] RTI International, Rockville, Maryland. ^[5] University of Pittsburgh, Pittsburgh, Pennsylvania. ^[6] Yale Medical School, New Haven, Connecticut. ^[7] Vitalant, Pittsburgh, Pennsylvania. ^[8] RTI International, Research Triangle Park, North Carolina. ^[9] American Red Cross, Dedham, Massachusetts. ^[10] University of British Columbia, Victoria, British Columbia, Canada. ^[11] Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey. ^[12]